Comparison of immunoglobulins and C3 in IgAV model group, DNase I intervention group and control group. حسب Xiu-Qi Chen (13832389)

الموضوعات:

The protein expression of MPO and citH3 in renal tissues. حسب Xiu-Qi Chen (13832389)

الموضوعات:

S1 File - حسب Xiu-Qi Chen (13832389)

الموضوعات:

Fig 6 - حسب Xiu-Qi Chen (13832389)

الموضوعات:

Fig 5 - حسب Xiu-Qi Chen (13832389)

الموضوعات:

Fig 4 - حسب Xiu-Qi Chen (13832389)

الموضوعات:

Loss of <i>Nf1</i> decreases sleep and increases metabolic rate in the SAMM system. حسب Elizabeth B. Brown (4582978)

Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and a... حسب Rehab F. Abdel-Rahman (11886404)

Decomposition of the Total Effect of statistically significant key independent variables on PTSD trajectories into Direct and Indirect Effects using the KHB method among postpartum... حسب Marelign Tilahun Malaju (12401482)

Few-Shot Symbol Detection in Engineering Drawings حسب Laura Jamieson (19759235)

الموضوعات:

Ydj1 acetylation impacts multiple aspects of translation. حسب Siddhi Omkar (12413434)

Results for the asymmetric relationship between military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Coefficient plot of short-run effects. حسب Ryan P. Thombs (9138968)

الموضوعات:

Seven forecast scenarios. حسب Ryan P. Thombs (9138968)

الموضوعات:

Annual Difference in Energy Consumption Relative to Historical Median Change by 2032. حسب Ryan P. Thombs (9138968)

الموضوعات:

Coefficient plot of long-run effects. حسب Ryan P. Thombs (9138968)

الموضوعات:

Results for the asymmetric relationship between military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Time series of military expenditures and DOD energy consumption. حسب Ryan P. Thombs (9138968)

الموضوعات:

Forecast for each scenario, 2023-2032. حسب Ryan P. Thombs (9138968)

الموضوعات:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات: